alpha-linolenic (omega3) and linoleic (omega6) acid metabolism (Homo sapiens)

From WikiPathways

Revision as of 11:23, 1 November 2018 by ReactomeTeam (Talk | contribs)
(diff) ←Older revision | Current revision (diff) | Newer revision→ (diff)
Jump to: navigation, search
2, 715, 273, 4, 15251, 9, 19128, 165, 22, 27125, 22, 3022, 2914, 218, 1722, 28, 30282510, 135, 2711, 20, 2614, 155, 22, 276, 18, 213, 4, 15, 23, 245, 27cellendoplasmic reticulum lumenperoxisomal matrixCO2DTA-CoANADHNAD+CoA-SHACSL1 NADPHELOVL1,2,3,5CO2NADP+FAD TPA-CoAELOVL5/ELOVL2CoA-SHadenosine5'-monophosphateCO2ELOVL1 ADP1-3-hydroxy-THA-CoAALAPiNADPHATPSCP2NADPHMalonyl-CoAELOVL5 ACOX1-2 ACSL1NAD+Malonyl-CoADHA-CoAO2Mg2+ ACOT8NADP+TPA-CoACoA-SHO2propionyl CoAELOVL2 NADP+DHACO2Ac-CoACoA-SHH2OATPMalonyl-CoANAD+CoA-SHFADS1ELOVL2 NADPHABCD1EPA-CoANADHACAA1DHAH2ONAD+NADHH2ONADPHNAD+NADHH2OH2OALA-CoAO2CoA-SHNADP+PPiHSD17B4 dimerCO2O2ADPELOVL5 adenosine5'-monophosphateH2O2CoA-SHFADS2DGL-CoANAD+THA-CoAELOVL3 CoA-SHDPAH2OH2ONADH1-3-oxo-THA-CoAETA-CoAH2OO2ELOVL2CoA-SHPIMalonyl-CoAGLA-CoAATPCoA-SHNADPHO2CO2H2OLINAPPiAA-CoAMalonyl-CoALA-CoAMalonyl-CoAH2ODPAH2OH2OSDA-CoAACOX1 dimerHSD17B4(1-736) H2OTHA-CoATPA-CoANADHDPA-CoATTA-CoAFADS2H2OATPdelta2-THA-CoAO2CoA-SH


Description

There are two major classes of polyunsaturated fatty acids (PUFAs): the omega-3 (n-3) and the omega-6 (n-6) fatty acids, where the number corresponds to the position of the first double bond proximate to the methyl end of the fatty acid. Omega-3 and omega-6 fatty acids are considered essential fatty acids. Humans cannot synthesize them, instead they are supplied through diet. Linoleic acid (LA, 18:2(n-6)), a major component of omega-6 fatty acids and alpha-linolenic acid (ALA, 18:2(n-3)) a major component of omega-3 fatty acids are the two main dietary essential fatty acids (EFAs) in humans. ALA and LA obtained from diet are converted in the body into their longer chain and more unsaturated omega-3 and omega-6 products by a series of desaturation and elongation steps. Metabolism of ALA and LA to their corresponding products is mediated via common enzyme systems. In humans ALA is finally converted to docosahexaenoic acid (DHA, C22:6(n-3)), and LA is converted to docosapentaenoic acid (DPA, C22:5(n-6)). The intermediary omega-3 and omega-6 series fatty acids play a significant role in health and disease by generating potent modulatory molecules for inflammatory responses, including eicosanoids (prostaglandins, and leukotrienes), and cytokines (interleukins) and affecting the gene expression of various bioactive molecules (Kapoor & Huang 2006, Sprecher 2002, Burdge 2006). View original pathway at:Reactome.

Comments

Reactome-Converter 
Pathway is converted from Reactome ID: 2046104
Reactome-version 
Reactome version: 66
Reactome Author 
Reactome Author: Garapati, Phani Vijay

Quality Tags

Ontology Terms

 

Bibliography

View all...
  1. Leonard AE, Bobik EG, Dorado J, Kroeger PE, Chuang LT, Thurmond JM, Parker-Barnes JM, Das T, Huang YS, Mukerji P.; ''Cloning of a human cDNA encoding a novel enzyme involved in the elongation of long-chain polyunsaturated fatty acids.''; PubMed
  2. Sprecher H.; ''Metabolism of highly unsaturated n-3 and n-6 fatty acids.''; PubMed
  3. Tang C, Cho HP, Nakamura MT, Clarke SD.; ''Regulation of human delta-6 desaturase gene transcription: identification of a functional direct repeat-1 element.''; PubMed
  4. Ge L, Gordon JS, Hsuan C, Stenn K, Prouty SM.; ''Identification of the delta-6 desaturase of human sebaceous glands: expression and enzyme activity.''; PubMed
  5. Moore SA, Hurt E, Yoder E, Sprecher H, Spector AA.; ''Docosahexaenoic acid synthesis in human skin fibroblasts involves peroxisomal retroconversion of tetracosahexaenoic acid.''; PubMed
  6. Ayala S, Gaspar G, Brenner RR, Peluffo RO, Kunau W.; ''Fate of linoleic, arachidonic, and docosa-7,10,13,16-tetraenoic acids in rat testicles.''; PubMed
  7. Sprecher H.; ''The roles of anabolic and catabolic reactions in the synthesis and recycling of polyunsaturated fatty acids.''; PubMed
  8. Cho HP, Nakamura M, Clarke SD.; ''Cloning, expression, and fatty acid regulation of the human delta-5 desaturase.''; PubMed
  9. Fan YY, Chapkin RS.; ''Importance of dietary gamma-linolenic acid in human health and nutrition.''; PubMed
  10. James MJ, Ursin VM, Cleland LG.; ''Metabolism of stearidonic acid in human subjects: comparison with the metabolism of other n-3 fatty acids.''; PubMed
  11. Kanayasu-Toyoda T, Morita I, Murota S.; ''Docosapentaenoic acid (22:5, n-3), an elongation metabolite of eicosapentaenoic acid (20:5, n-3), is a potent stimulator of endothelial cell migration on pretreatment in vitro.''; PubMed
  12. Hunt MC, Alexson SE.; ''Novel functions of acyl-CoA thioesterases and acyltransferases as auxiliary enzymes in peroxisomal lipid metabolism.''; PubMed
  13. Parker-Barnes JM, Das T, Bobik E, Leonard AE, Thurmond JM, Chaung LT, Huang YS, Mukerji P.; ''Identification and characterization of an enzyme involved in the elongation of n-6 and n-3 polyunsaturated fatty acids.''; PubMed
  14. Voss A, Reinhart M, Sankarappa S, Sprecher H.; ''The metabolism of 7,10,13,16,19-docosapentaenoic acid to 4,7,10,13,16,19-docosahexaenoic acid in rat liver is independent of a 4-desaturase.''; PubMed
  15. D'andrea S, Guillou H, Jan S, Catheline D, Thibault JN, Bouriel M, Rioux V, Legrand P.; ''The same rat Delta6-desaturase not only acts on 18- but also on 24-carbon fatty acids in very-long-chain polyunsaturated fatty acid biosynthesis.''; PubMed
  16. Cantrill RC, Huang YS, Ells GW, Horrobin DF.; ''Comparison of the metabolism of alpha-linolenic acid and its delta 6 desaturation product, stearidonic acid, in cultured NIH-3T3 cells.''; PubMed
  17. Leonard AE, Kelder B, Bobik EG, Chuang LT, Parker-Barnes JM, Thurmond JM, Kroeger PE, Kopchick JJ, Huang YS, Mukerji P.; ''cDNA cloning and characterization of human Delta5-desaturase involved in the biosynthesis of arachidonic acid.''; PubMed
  18. Bridges RB, Coniglio JG.; ''The biosynthesis of delta-9,12,15,18-tetracosatetraenoic and of delta-6,9,12,15,18-tetracosapentaenoic acids by rat testes.''; PubMed
  19. Chilton-Lopez, Surette ME, Swan DD, Fonteh AN, Johnson MM, Chilton FH.; ''Metabolism of gammalinolenic acid in human neutrophils.''; PubMed
  20. Burdge GC, Wootton SA.; ''Conversion of alpha-linolenic acid to eicosapentaenoic, docosapentaenoic and docosahexaenoic acids in young women.''; PubMed
  21. Leonard AE, Pereira SL, Sprecher H, Huang YS.; ''Elongation of long-chain fatty acids.''; PubMed
  22. Su HM, Moser AB, Moser HW, Watkins PA.; ''Peroxisomal straight-chain Acyl-CoA oxidase and D-bifunctional protein are essential for the retroconversion step in docosahexaenoic acid synthesis.''; PubMed
  23. Yamazaki K, Fujikawa M, Hamazaki T, Yano S, Shono T.; ''Comparison of the conversion rates of alpha-linolenic acid (18:3(n - 3)) and stearidonic acid (18:4(n - 3)) to longer polyunsaturated fatty acids in rats.''; PubMed
  24. Whelan J.; ''Dietary stearidonic acid is a long chain (n-3) polyunsaturated fatty acid with potential health benefits.''; PubMed
  25. Wilson DB, Prescott SM, Majerus PW.; ''Discovery of an arachidonoyl coenzyme A synthetase in human platelets.''; PubMed
  26. Burdge GC, Jones AE, Wootton SA.; ''Eicosapentaenoic and docosapentaenoic acids are the principal products of alpha-linolenic acid metabolism in young men*.''; PubMed
  27. Ferdinandusse S, Denis S, Mooijer PA, Zhang Z, Reddy JK, Spector AA, Wanders RJ.; ''Identification of the peroxisomal beta-oxidation enzymes involved in the biosynthesis of docosahexaenoic acid.''; PubMed
  28. Infante JP, Huszagh VA.; ''Analysis of the putative role of 24-carbon polyunsaturated fatty acids in the biosynthesis of docosapentaenoic (22:5n-6) and docosahexaenoic (22:6n-3) acids.''; PubMed
  29. Ellis JM, Frahm JL, Li LO, Coleman RA.; ''Acyl-coenzyme A synthetases in metabolic control.''; PubMed
  30. Ferdinandusse S, Denis S, Dacremont G, Wanders RJ.; ''Studies on the metabolic fate of n-3 polyunsaturated fatty acids.''; PubMed

History

View all...
CompareRevisionActionTimeUserComment
101350view11:23, 1 November 2018ReactomeTeamreactome version 66
100888view20:57, 31 October 2018ReactomeTeamreactome version 65
100429view19:31, 31 October 2018ReactomeTeamreactome version 64
99978view16:15, 31 October 2018ReactomeTeamreactome version 63
99532view14:51, 31 October 2018ReactomeTeamreactome version 62 (2nd attempt)
93871view13:42, 16 August 2017ReactomeTeamreactome version 61
93438view11:23, 9 August 2017ReactomeTeamreactome version 61
87080view14:22, 18 July 2016MkutmonOntology Term : 'lipid metabolic pathway' added !
86529view09:20, 11 July 2016ReactomeTeamreactome version 56
83127view10:02, 18 November 2015ReactomeTeamVersion54
81467view13:00, 21 August 2015ReactomeTeamVersion53
76941view08:21, 17 July 2014ReactomeTeamFixed remaining interactions
76646view12:01, 16 July 2014ReactomeTeamFixed remaining interactions
75976view10:03, 11 June 2014ReactomeTeamRe-fixing comment source
75679view11:00, 10 June 2014ReactomeTeamReactome 48 Update
75034view13:54, 8 May 2014AnweshaFixing comment source for displaying WikiPathways description
74678view08:44, 30 April 2014ReactomeTeamNew pathway

External references

DataNodes

View all...
NameTypeDatabase referenceComment
1-3-hydroxy-THA-CoAMetaboliteCHEBI:65130 (ChEBI)
1-3-oxo-THA-CoAMetaboliteCHEBI:65131 (ChEBI)
AA-CoAMetaboliteCHEBI:15514 (ChEBI)
ABCD1ProteinP33897 (Uniprot-TrEMBL)
ACAA1ProteinP09110 (Uniprot-TrEMBL)
ACOT8ProteinO14734 (Uniprot-TrEMBL)
ACOX1 dimerComplexR-HSA-390232 (Reactome)
ACOX1-2 ProteinQ15067-2 (Uniprot-TrEMBL)
ACSL1 ProteinP33121 (Uniprot-TrEMBL)
ACSL1ComplexR-HSA-2046075 (Reactome)
ADPMetaboliteCHEBI:16761 (ChEBI)
ALA-CoAMetaboliteCHEBI:51985 (ChEBI)
ALAMetaboliteCHEBI:27432 (ChEBI)
ATPMetaboliteCHEBI:15422 (ChEBI)
Ac-CoAMetaboliteCHEBI:15351 (ChEBI)
CO2MetaboliteCHEBI:16526 (ChEBI)
CoA-SHMetaboliteCHEBI:15346 (ChEBI)
DGL-CoAMetaboliteCHEBI:27979 (ChEBI)
DHA-CoAMetaboliteCHEBI:65132 (ChEBI)
DHAMetaboliteCHEBI:28125 (ChEBI)
DPA-CoAMetaboliteCHEBI:63541 (ChEBI)
DPAMetaboliteCHEBI:65136 (ChEBI)
DTA-CoAMetaboliteCHEBI:63544 (ChEBI)
ELOVL1 ProteinQ9BW60 (Uniprot-TrEMBL)
ELOVL1,2,3,5ComplexR-HSA-5676214 (Reactome)
ELOVL2 ProteinQ9NXB9 (Uniprot-TrEMBL)
ELOVL2ProteinQ9NXB9 (Uniprot-TrEMBL)
ELOVL3 ProteinQ9HB03 (Uniprot-TrEMBL)
ELOVL5 ProteinQ9NYP7 (Uniprot-TrEMBL)
ELOVL5/ELOVL2ComplexR-HSA-2046072 (Reactome)
EPA-CoAMetaboliteCHEBI:63539 (ChEBI)
ETA-CoAMetaboliteCHEBI:63542 (ChEBI)
FAD MetaboliteCHEBI:16238 (ChEBI)
FADS1ProteinO60427 (Uniprot-TrEMBL)
FADS2ProteinO95864 (Uniprot-TrEMBL)
GLA-CoAMetaboliteCHEBI:15508 (ChEBI)
H2O2MetaboliteCHEBI:16240 (ChEBI)
H2OMetaboliteCHEBI:15377 (ChEBI)
HSD17B4 dimerComplexR-HSA-389999 (Reactome)
HSD17B4(1-736) ProteinP51659 (Uniprot-TrEMBL)
LA-CoAMetaboliteCHEBI:15530 (ChEBI)
LINAMetaboliteCHEBI:17351 (ChEBI)
Malonyl-CoAMetaboliteCHEBI:15531 (ChEBI)
Mg2+ MetaboliteCHEBI:18420 (ChEBI)
NAD+MetaboliteCHEBI:15846 (ChEBI)
NADHMetaboliteCHEBI:16908 (ChEBI)
NADP+MetaboliteCHEBI:18009 (ChEBI)
NADPHMetaboliteCHEBI:16474 (ChEBI)
O2MetaboliteCHEBI:15379 (ChEBI)
PIMetaboliteCHEBI:16749 (ChEBI)
PPiMetaboliteCHEBI:29888 (ChEBI)
PiMetaboliteCHEBI:18367 (ChEBI)
SCP2ProteinP22307 (Uniprot-TrEMBL)
SDA-CoAMetaboliteCHEBI:63545 (ChEBI)
THA-CoAMetaboliteCHEBI:63540 (ChEBI)
TPA-CoAMetaboliteCHEBI:63543 (ChEBI)
TPA-CoAMetaboliteCHEBI:63546 (ChEBI)
TTA-CoAMetaboliteCHEBI:63548 (ChEBI)
adenosine 5'-monophosphateMetaboliteCHEBI:16027 (ChEBI)
delta2-THA-CoAMetaboliteCHEBI:65139 (ChEBI)
propionyl CoAMetaboliteCHEBI:15539 (ChEBI)

Annotated Interactions

View all...
SourceTargetTypeDatabase referenceComment
1-3-hydroxy-THA-CoAArrowR-HSA-2066778 (Reactome)
1-3-hydroxy-THA-CoAR-HSA-2066780 (Reactome)
1-3-oxo-THA-CoAArrowR-HSA-2066780 (Reactome)
1-3-oxo-THA-CoAR-HSA-2066781 (Reactome)
1-3-oxo-THA-CoAR-HSA-2066788 (Reactome)
AA-CoAArrowR-HSA-2046092 (Reactome)
AA-CoAR-HSA-2046083 (Reactome)
ABCD1mim-catalysisR-HSA-2046087 (Reactome)
ABCD1mim-catalysisR-HSA-2046093 (Reactome)
ACAA1mim-catalysisR-HSA-2066788 (Reactome)
ACOT8mim-catalysisR-HSA-2066779 (Reactome)
ACOX1 dimermim-catalysisR-HSA-2066787 (Reactome)
ACSL1mim-catalysisR-HSA-2046085 (Reactome)
ACSL1mim-catalysisR-HSA-2046098 (Reactome)
ADPArrowR-HSA-2046087 (Reactome)
ADPArrowR-HSA-2046093 (Reactome)
ALA-CoAArrowR-HSA-2046085 (Reactome)
ALA-CoAR-HSA-2046084 (Reactome)
ALAR-HSA-2046085 (Reactome)
ATPR-HSA-2046085 (Reactome)
ATPR-HSA-2046087 (Reactome)
ATPR-HSA-2046093 (Reactome)
ATPR-HSA-2046098 (Reactome)
Ac-CoAArrowR-HSA-2066788 (Reactome)
CO2ArrowR-HSA-2046083 (Reactome)
CO2ArrowR-HSA-2046088 (Reactome)
CO2ArrowR-HSA-2046090 (Reactome)
CO2ArrowR-HSA-2046094 (Reactome)
CO2ArrowR-HSA-2046095 (Reactome)
CO2ArrowR-HSA-2046100 (Reactome)
CoA-SHArrowR-HSA-2046083 (Reactome)
CoA-SHArrowR-HSA-2046088 (Reactome)
CoA-SHArrowR-HSA-2046090 (Reactome)
CoA-SHArrowR-HSA-2046094 (Reactome)
CoA-SHArrowR-HSA-2046095 (Reactome)
CoA-SHArrowR-HSA-2046100 (Reactome)
CoA-SHArrowR-HSA-2066779 (Reactome)
CoA-SHR-HSA-2046085 (Reactome)
CoA-SHR-HSA-2046098 (Reactome)
CoA-SHR-HSA-2066781 (Reactome)
CoA-SHR-HSA-2066788 (Reactome)
DGL-CoAArrowR-HSA-2046094 (Reactome)
DGL-CoAR-HSA-2046092 (Reactome)
DHA-CoAArrowR-HSA-2066781 (Reactome)
DHA-CoAArrowR-HSA-2066788 (Reactome)
DHA-CoAR-HSA-2066779 (Reactome)
DHAArrowR-HSA-2066779 (Reactome)
DHAArrowR-HSA-2066785 (Reactome)
DHAR-HSA-2066785 (Reactome)
DPA-CoAArrowR-HSA-2046100 (Reactome)
DPA-CoAR-HSA-2046090 (Reactome)
DPAArrowR-HSA-2046101 (Reactome)
DPAArrowR-HSA-2066782 (Reactome)
DPAR-HSA-2066782 (Reactome)
DTA-CoAArrowR-HSA-2046083 (Reactome)
DTA-CoAR-HSA-2046095 (Reactome)
ELOVL1,2,3,5mim-catalysisR-HSA-2046088 (Reactome)
ELOVL1,2,3,5mim-catalysisR-HSA-2046094 (Reactome)
ELOVL2mim-catalysisR-HSA-2046090 (Reactome)
ELOVL2mim-catalysisR-HSA-2046095 (Reactome)
ELOVL5/ELOVL2mim-catalysisR-HSA-2046083 (Reactome)
ELOVL5/ELOVL2mim-catalysisR-HSA-2046100 (Reactome)
EPA-CoAArrowR-HSA-2046089 (Reactome)
EPA-CoAR-HSA-2046100 (Reactome)
ETA-CoAArrowR-HSA-2046088 (Reactome)
ETA-CoAR-HSA-2046089 (Reactome)
FADS1mim-catalysisR-HSA-2046089 (Reactome)
FADS1mim-catalysisR-HSA-2046092 (Reactome)
FADS2mim-catalysisR-HSA-2046084 (Reactome)
FADS2mim-catalysisR-HSA-2046096 (Reactome)
FADS2mim-catalysisR-HSA-2046097 (Reactome)
FADS2mim-catalysisR-HSA-2046099 (Reactome)
GLA-CoAArrowR-HSA-2046096 (Reactome)
GLA-CoAR-HSA-2046094 (Reactome)
H2O2ArrowR-HSA-2066787 (Reactome)
H2OArrowR-HSA-2046083 (Reactome)
H2OArrowR-HSA-2046084 (Reactome)
H2OArrowR-HSA-2046088 (Reactome)
H2OArrowR-HSA-2046089 (Reactome)
H2OArrowR-HSA-2046090 (Reactome)
H2OArrowR-HSA-2046092 (Reactome)
H2OArrowR-HSA-2046094 (Reactome)
H2OArrowR-HSA-2046095 (Reactome)
H2OArrowR-HSA-2046096 (Reactome)
H2OArrowR-HSA-2046097 (Reactome)
H2OArrowR-HSA-2046099 (Reactome)
H2OArrowR-HSA-2046100 (Reactome)
H2OR-HSA-2066778 (Reactome)
H2OR-HSA-2066779 (Reactome)
HSD17B4 dimermim-catalysisR-HSA-2066778 (Reactome)
HSD17B4 dimermim-catalysisR-HSA-2066780 (Reactome)
LA-CoAArrowR-HSA-2046098 (Reactome)
LA-CoAR-HSA-2046096 (Reactome)
LINAR-HSA-2046098 (Reactome)
Malonyl-CoAR-HSA-2046083 (Reactome)
Malonyl-CoAR-HSA-2046088 (Reactome)
Malonyl-CoAR-HSA-2046090 (Reactome)
Malonyl-CoAR-HSA-2046094 (Reactome)
Malonyl-CoAR-HSA-2046095 (Reactome)
Malonyl-CoAR-HSA-2046100 (Reactome)
NAD+ArrowR-HSA-2046084 (Reactome)
NAD+ArrowR-HSA-2046089 (Reactome)
NAD+ArrowR-HSA-2046092 (Reactome)
NAD+ArrowR-HSA-2046096 (Reactome)
NAD+ArrowR-HSA-2046097 (Reactome)
NAD+ArrowR-HSA-2046099 (Reactome)
NADHR-HSA-2046084 (Reactome)
NADHR-HSA-2046089 (Reactome)
NADHR-HSA-2046092 (Reactome)
NADHR-HSA-2046096 (Reactome)
NADHR-HSA-2046097 (Reactome)
NADHR-HSA-2046099 (Reactome)
NADP+ArrowR-HSA-2046088 (Reactome)
NADP+ArrowR-HSA-2046090 (Reactome)
NADP+ArrowR-HSA-2046094 (Reactome)
NADP+ArrowR-HSA-2046100 (Reactome)
NADPHR-HSA-2046083 (Reactome)
NADPHR-HSA-2046088 (Reactome)
NADPHR-HSA-2046090 (Reactome)
NADPHR-HSA-2046094 (Reactome)
NADPHR-HSA-2046095 (Reactome)
NADPHR-HSA-2046100 (Reactome)
O2R-HSA-2046084 (Reactome)
O2R-HSA-2046089 (Reactome)
O2R-HSA-2046092 (Reactome)
O2R-HSA-2046096 (Reactome)
O2R-HSA-2046097 (Reactome)
O2R-HSA-2046099 (Reactome)
O2R-HSA-2066787 (Reactome)
PIArrowR-HSA-2046087 (Reactome)
PPiArrowR-HSA-2046085 (Reactome)
PPiArrowR-HSA-2046098 (Reactome)
PiArrowR-HSA-2046093 (Reactome)
R-HSA-2046083 (Reactome) Arachidonyl-CoA undergoes a two-carbon chain elongation on the carboxyl end to form docosatetraenoyl-CoA (DTA-CoA/Adrenic acid/7,10,13,16-docosatetraenoic acid (7,10,13,16-22:4(n-6)). This reaction is catalyzed by the enzymes ELOVL5 or ELOVL2. Malanoyl-CoA provides the additional two carbons required for elongation. Docosatetraenoyl-CoA is further metabolized by cyclooxygenases (COX), lipoxygenases (LO) and cytochrome P450s (CYP450s) to dihomo (DH) eicosanoids (Kopf et al. 2010, Leonard et al. 2004).
R-HSA-2046084 (Reactome) Alpha-linoloyl-CoA is converted to Stearidonoyl-CoA (SDA, 6,9,12,15-18:3(n-3)) by delta-6-destaurase (fatty acid desaturase-2, FADS2). FADS2 uses the cytochrome b5 system to add a double bond at position 6. This is the rate limiting step in alpha-linolenic acid (ALA) metabolism (Horrobin 1993).
R-HSA-2046085 (Reactome) In the first step the precursor apha-linolenic (9,12,15-18:3(n-3)) acid is activated to a high energy form known as alpha-linolenoyl-CoA (9Z,12Z,15Z-octadecatrienoyl-CoA) by the iron enzyme long-chain-fatty-acid-CoA-ligase (acyl-CoA synthetase 1, ACSL1) and coenzyme A.
R-HSA-2046087 (Reactome) The 24-carbon tetracosahexaenoyl-CoA (6,9,12,15,18,21-24:6(n-3) is transported to peroxisomes to undergo a putative single cycle of peroxisomal beta-oxidation, producing Docosahexaenoic Acid (DHA) (Sprecher 2002, Luthria et al. 1996).
R-HSA-2046088 (Reactome) SDA-CoA (6,9,12,15-18:4(n-3)) is rapidly elongated by two carbon atoms to 8,11,14,17-eicosatetraenoyl-CoA (8,11,14,17-20:4(n-3), ETA-CoA). The NADPH-consuming enzyme long-chain fatty acyl elongase (ELOVL5) mediates this reaction which and adds malonyl-CoA to the SDA-CoA and releases carbon dioxide and free CoA (Leonard et al. 2004).
R-HSA-2046089 (Reactome) Eicosatetraenoyl-CoA (ETA-CoA) is desaturated by an additional carbon-carbon bond to form 5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl-CoA (EPA-CoA, 5,8,11,14,17-20:5(n-3)). Delta-5-desaturase is required for this conversion. EPA-CoA has health benefits due to its anti-inflammatory actions. It is a precursor for the anti-inflammatory series-3 prostaglandins (PG), the series-5 leukotrienes (LT) and the series-3 thromboxanes (TA), which are anti-atherogenic and anti-thrombogenic (Ross et al. 2009).
R-HSA-2046090 (Reactome) Docosapentaenoyl-CoA is elongated to tetracosapentaenoyl-CoA (9,12,15,18,21-24:5(n-3)) by the enzyme ELOVL2.
R-HSA-2046092 (Reactome) DGL-CoA (8,11,14-eicosatrienoyl-CoA) undergoes desaturation by delta 5-desaturase (D5-desaturase) forming arachidonoyl-CoA (AA-CoA, 5,8,11,14-Eicosatetraenoic acid). D5-desaturase has 62% sequence identity with D6-desaturase but desaturates a different carbon atom, adding a double bond at position C5 in arachidonoyl-CoA (AA-CoA). AA can be metabolized by variety of oxygenases (including cyclo-oxygenase and lipoxygenase systems) to form a family of varying products known as eicosanoids, prostaglandins, leukotrines and thromboxanes thus playing important role in inflamation response.
R-HSA-2046093 (Reactome) Prior to this reaction all the enzymes involved in the desaturation and elongation of linoleic acid are located in the ER, but for this last step tetracosapentaenoyl-CoA must be transferred to the peroxisomes for partial beta-oxidation to docosapentaenoyl-CoA (DPA-CoA, 4,7,10,13,16-22:5(n-6)) (Su et al. 2001).
R-HSA-2046094 (Reactome) Gamma-linolenoyl-CoA (6,9,12-20:3(n-6)) is rapidly elongated to dihomo-gamma-linolenoyl-CoA (DGL-CoA; 8,11,14-20:3(n-6)) by the action of C18-PUFA-specific elongase 5 (ELOVL5). Two carbon atoms are added during this reaction. DGL-CoA later undergoes desaturation to form arachidonic acid (AA, 5,8,11,14-20:4(n-6)).
Depending on the cell type, DGL-CoA can also be metabolized by cyclooxygenases and lipoxygenases to produce anti-inflammatory eicosanoids (prostaglandins of series 1 (PGE1) and 15-hydroxyeico- satrienoic acid (15-HETrE)). GLA and these two oxidative metabolites exert clinical effects in a variety of diseases, including suppression of chronic inflammation, vasodilation and lowering of blood pressure, inhibition of platelet aggregation and thrombosis. (Fan et al. 2001, Fan & Chapkin 1998, Kapoor & Huang. 2006)
R-HSA-2046095 (Reactome) Docosatetraenoyl-CoA is elongated to tetracosatetraenoyl-CoA (TTA-CoA, 9,12,15,18-tetracosatetraenoic acid, 9,12,15,18-24:4(n-6)) by the elongase enzyme ELOVL2.
R-HSA-2046096 (Reactome) The first major step in the metabolism of linoleic acid (LA) is desaturation of delta 9,12-octadecadienoyl CoA/linoleoyl CoA (LA-CoA) to delta 6,9,12-octodecatrienoyl CoA/gamma-lenoleoyl CoA (GLA-CoA). This step is catalyzed by delta-6-destaurase (fatty acid desaturase-2, FADS2) which introduces a cis-double bond between carbons 6 and 7. This is the rate limiting step in LA metabolism (Horrobin 1993).
R-HSA-2046097 (Reactome) Tetracosatetraenoyl-CoA is further desaturated by delta 6-desaturase (FADS2) to tetracosapentaenoyl-CoA (TPA-CoA, 6,9,12,15,18-24:5(n-6)).
R-HSA-2046098 (Reactome) The dietary essential fatty acid (EFA) linoleic acid (LA) is activated to a high energy form known as linoleoyl-CoA by the action of long-chain acyl-CoA synthetases (ACSLs). Thioesterification of long-chain fatty acids into their acyl-CoA derivatives is considered to be the first committed step in fatty acid metabolism. Formation of acyl-CoA allows an otherwise non-reactive fatty acid to participate in biosynthetic or catabolic pathways. This acyl CoA form is converted to its longer-chain polyunsaturated products by a series of desaturation and elongation reactions (Ellis et al. 2010, Watkins 2008).
R-HSA-2046099 (Reactome) Tetracosapentaenoyl-CoA (9,12,15,18,21-24:5(n-3)) is further converted by delta 6-desaturase (FADS2) to tetracosahexaenoyl-CoA (6,9,12,15,18,21-24:6(n-3)).
R-HSA-2046100 (Reactome) Eicosapentaenoyl-CoA (EPA-CoA) is transformed to docosapentaenoyl-CoA (DPA-CoA/clupanodonic acid; 7,10,13,16,19-22:5(n-3)) by addition of two carbon atoms from malanoyl-CoA. This reaction is catalyzed by the enzymes ELOVL5/2 (Leonard et al. 2004). DPA is quite high in seal oil and may act as an anti-atherogenic factor. DPA has 10-fold greater endothelial cell migration ability than EPA, which is important in wound-healing processes. DPA may act as a precursor for production of the DPA-related D-series of resolvins or neuroprotectins (Kaur et al. 2011).
R-HSA-2046101 (Reactome) One cycle of peroxisomal beta-oxidation shortens C24:5(n-6) to C22:5(n-6), releasing one molecules of acetyl-CoA. Peroxisomal acyl-coenzyme A oxidase 1 (AOX), D-bifunctional protein (DBP/MFE2), and either peroxisomal 3-oxoacyl-CoA thiolase (Th) or SCPx thiolase (SCPx) enzymes have been proposed to be responsible for this partial beta-oxidation (Infante & Huszagh 1998, Su et al. 2001).
R-HSA-2066778 (Reactome) Delta2-THA-CoA is hydrated to 3-hydroxyacyl-CoA intermediate 1-(3-hydroxy-6Z,9Z,12Z,15Z,18Z,21Z-tetracosahexaenoyl)-CoA by HSD17B4/DBP (d-bifunctional protein) dimer.
R-HSA-2066779 (Reactome) DHA-CoA preferentially moves back to the ER, perhaps as a free fatty acid. This conversion is usually catalysed by acyl-CoA thioesterases (ACOTs). No specific acyl-CoA thioesterase enzyme has been identified for the peroxisomal metabolism of DHA-CoA, but the peroxisomal ACOT8 has a wide substrate specificity and is likely to be responsible (Ferdinandusse et al. 2003, Hunt & Alexson. 2008).
R-HSA-2066780 (Reactome) 3-hydroxy tetracosahexaenoyl-CoA undergoes dehydrogenation to form 1-(3-oxo-6Z,9Z,12Z,15Z,18Z,21Z-tetracosahexaenoyl)-CoA, catalysed by DBP. DBP is a bifunctional enzyme, involved in the hydration of a variety of trans-2,3-dehydroacyl-CoA's but also mediating dehydrogenation of a variety of 3-hydroxyacyl-CoA's (Jiang et al. 1997).
R-HSA-2066781 (Reactome) The final step in the beta-oxidation process is the thiolytic cleavage of 1-(3-oxo-6Z,9Z,12Z,15Z,18Z,21Z-tetracosahexaenoyl)-CoA to form docosahexaenoyl-CoA (DHA-CoA). This step is catalysed by both sterol carrier protein X (SCPx) (this reaction) and the classic 3-ketoacyl-CoA thiolase (Ferdinandusse et al. 2001).
R-HSA-2066782 (Reactome) The resulted free DPA is transported back to ER, where it is incorporated into membrane lipids.
R-HSA-2066785 (Reactome) DHA is transported back to the ER, where it is incorporated into membrane lipids instead of being further beta-oxidized in the peroxisome (Ferdinandusse et al. 2003).
R-HSA-2066787 (Reactome) Retroconversion of C24:6(n-3) to docosahexaenoic acid (22:6(n-3) involves the initial oxidation of tetracosahexaenoyl-CoA to an intermediate 1-(2E,6Z,9Z,12Z,15Z,18Z,21Z-tetracosaheptaenoyl)-CoA (delta2-THA-CoA). This step is catalysed by the peroxisomal enzyme Straight-chain acyl-CoA oxidase (SCOX) (Ferdinandusse et al. 2001).
R-HSA-2066788 (Reactome) The final step in the beta-oxidation process is the thiolytic cleavage of 1-(3-oxo-6Z,9Z,12Z,15Z,18Z,21Z-tetracosahexaenoyl)-CoA to form docosahexaenoyl-CoA (DHA-CoA). This step is catalysed by both sterol carrier protein X (SCPx) and the classic 3-ketoacyl-CoA thiolase (this reaction) (Ferdinandusse et al. 2001).
SCP2mim-catalysisR-HSA-2066781 (Reactome)
SDA-CoAArrowR-HSA-2046084 (Reactome)
SDA-CoAR-HSA-2046088 (Reactome)
THA-CoAArrowR-HSA-2046087 (Reactome)
THA-CoAArrowR-HSA-2046099 (Reactome)
THA-CoAR-HSA-2046087 (Reactome)
THA-CoAR-HSA-2066787 (Reactome)
TPA-CoAArrowR-HSA-2046090 (Reactome)
TPA-CoAArrowR-HSA-2046093 (Reactome)
TPA-CoAArrowR-HSA-2046097 (Reactome)
TPA-CoAR-HSA-2046093 (Reactome)
TPA-CoAR-HSA-2046099 (Reactome)
TPA-CoAR-HSA-2046101 (Reactome)
TTA-CoAArrowR-HSA-2046095 (Reactome)
TTA-CoAR-HSA-2046097 (Reactome)
adenosine 5'-monophosphateArrowR-HSA-2046085 (Reactome)
adenosine 5'-monophosphateArrowR-HSA-2046098 (Reactome)
delta2-THA-CoAArrowR-HSA-2066787 (Reactome)
delta2-THA-CoAR-HSA-2066778 (Reactome)
propionyl CoAArrowR-HSA-2066781 (Reactome)
Personal tools